慢性乙型肝炎抗病毒治疗:从不断扩大治疗到全面治疗势在必行  

Antiviral therapy for chronic hepatitis B: the imperative to move from scaling-up treatment to full treatment

作　　者：盛秋菊[1] 窦晓光[1] Sheng Qiuju;Dou Xiaoguang(Department of Infectious Diseases,Shengjing Hospital of China Medical University,Liaoning Province Key Laboratory of Viral Hepatitis,Shenyang 110022,China)

机构地区：[1]中国医科大学附属盛京医院、辽宁省病毒性肝炎重点实验室,沈阳1110022

出　　处：《中华肝脏病杂志》2023年第3期225-227,共3页Chinese Journal of Hepatology

摘　　要：对慢性乙型肝炎患者及时有效的抗病毒治疗,可以阻止或延缓疾病进展为肝硬化、肝衰竭或肝细胞癌。基于目前对疾病进展新的认识,以及肝功能检测异常值界定等的变化,抗病毒治疗的适应证在不断扩大,最终将实现只要病毒阳性都治疗。Timely and effective antiviral therapy can prevent or delay the progression of the disease to cirrhosis,liver failure,or hepatocellular carcinoma in patients with chronic hepatitis B.Antiviral therapy indications are constantly expanding,and eventually it will be manageable to treat viral positives based on the new understanding of the disease progression and the changes in the definition of abnormal values in liver function tests.

关 键 词：慢性乙型肝炎 抗病毒治疗 扩大和全面治疗 

分 类 号：R512.62[医药卫生—内科学]